Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

被引:28
|
作者
Diz-Chaves, Yolanda [1 ]
Herrera-Perez, Salvador [2 ]
Gonzalez-Matias, Lucas C. [1 ]
Lamas, Jose Antonio [2 ]
Mallo, Federico [1 ]
机构
[1] Univ Vigo, Lab Endocrinol, CINBIO, Grp FB3A, Vigo 36310, Spain
[2] Univ Vigo, Lab Neurociencia, CINBIO, Grp FB3A, Vigo 36310, Spain
关键词
glucagon-like peptide-1; hypothalamic-pituitary-adrenal (HPA) axis; sympathetic nervous system (SNS); ion channels; food intake; BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL-AXIS; NUCLEUS-TRACTUS-SOLITARIUS; RECEPTOR-EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; PANCREATIC BETA-CELLS; REDUCES FOOD-INTAKE; HEART-RATE; ENERGY-BALANCE;
D O I
10.3390/nu12113304
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glucagon like-peptide 1 (GLP-1) within the brain is produced by a population of preproglucagon neurons located in the caudal nucleus of the solitary tract. These neurons project to the hypothalamus and another forebrain, hindbrain, and mesolimbic brain areas control the autonomic function, feeding, and the motivation to feed or regulate the stress response and the hypothalamic-pituitary-adrenal axis. GLP-1 receptor (GLP-1R) controls both food intake and feeding behavior (hunger-driven feeding, the hedonic value of food, and food motivation). The activation of GLP-1 receptors involves second messenger pathways and ionic events in the autonomic nervous system, which are very relevant to explain the essential central actions of GLP-1 as neuromodulator coordinating food intake in response to a physiological and stress-related stimulus to maintain homeostasis. Alterations in GLP-1 signaling associated with obesity or chronic stress induce the dysregulation of eating behavior. This review summarized the experimental shreds of evidence from studies using GLP-1R agonists to describe the neural and endocrine integration of stress responses and feeding behavior.
引用
收藏
页码:1 / 32
页数:32
相关论文
共 50 条
  • [21] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
  • [22] STRUCTURE OF HUMAN GLP-1(GLUCAGON-LIKE PEPTIDE-1) CONTAINING PEPTIDES
    ORSKOV, C
    KOFOD, H
    RABENHOJ, L
    WETTERGREN, A
    HOLST, JJ
    DIABETOLOGIA, 1992, 35 : A109 - A109
  • [23] Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses
    Rehman, Kanwal
    Ali, Mehwish Bagh
    Akash, Muhammad Sajid Hamid
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
  • [24] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
  • [25] Glucagon-like peptide-1 (GLP-1) signalling in the brain: From neural circuits and metabolism to therapeutics
    Kabahizi, Anita
    Wallace, Briana
    Lieu, Linh
    Chau, Dominic
    Dong, Yanbin
    Hwang, Eun-Sang
    Williams, Kevin W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 600 - 624
  • [26] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
    Li, Ya-Kun
    Ma, Dong-Xia
    Wang, Zhi-Min
    Hu, Xiao-Fan
    Li, Shang-Lin
    Tian, Hong-Zhe
    Wang, Meng-Jun
    Shu, Yan-Wen
    Yang, Jun
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 102 - 111
  • [27] Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion
    Hansen, L
    Mineo, H
    Bisgaard, T
    Jorgensen, PN
    Holst, JJ
    DIABETOLOGIA, 1997, 40 : 498 - 498
  • [28] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Abba J. Kastin
    Victoria Akerstrom
    Weihong Pan
    Journal of Molecular Neuroscience, 2002, 18 : 7 - 14
  • [29] Can glucagon-like peptide-1(GLP-1) analogues make neuroprotection a reality?
    Maryna V.Basalay
    Sean M.Davidson
    Derek M.Yellon
    Neural Regeneration Research, 2020, 15 (10) : 1852 - 1853
  • [30] Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
    Kawatani, Masahiro
    Yamada, Yuichiro
    Kawatani, Masahito
    PEPTIDES, 2018, 107 : 68 - 74